iBio - M&A Summary and Business Overview

Life ScienceCompany

iBio M&A Summary

iBio has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2024, when it sold iBio - Preclinical PD-1 Agonist Antibody Program to Otsuka Pharmaceutical for $53M. iBio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

iBio Business Overview

Where is iBio headquartered?

iBio is headquartered in Bryan, Texas.

What is iBio’s revenue?

iBio disclosed revenue of 2M USD for 2021 and 2M USD for 2020.

How many employees does iBio have?

iBio has 26 employees.

What sector is iBio in?

iBio is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

iBio

iBio, Inc.

8800 HSC Parkway,
Bryan, Texas 77807
United States,
(979) 446-0027
www.ibioinc.com

iBio develops next-generation biopharmaceuticals using computational biology and 3D-modeling of hard-to-target subdominant epitopes along with its sustainable, plant-based protein expression capabilities for cGMP manufacturing. iBio is based in Bryan, Texas.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - 1 - - 1
Sell (0.2/yr) # - - - - - 1 1
vol $53M $53M
  2

Most Recent M&A

Company Date Value Type
iBio - Preclinical PD-1 Agonist Antibody Program 2024-02-25 53M USD Divestiture
Bryan, Texas
RubrYc Therapeutics, Inc. 2022-09-21 - Add-on Acquisition
San Carlos, California · www.rubryc.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 1 (100%) 53M (100%)
Total 1 - 1 $53M

By Geo

State/Country Buy Value Sell Value
United States 1 - 1 53M
  California 1 - - -
  Texas - - 1 53M
Total 1 - 1 $53M

Deal Values

sell # Total
< $100M 1 $53M
TOTAL $53M
Largest iBio - Preclinical PD-1 Agonist Antibody Program
$53M (2024-02-25)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.